Across TCGA pan-cancer cohorts, MIR4503 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR4503 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR4503 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4503 expression acts as an unfavorable survival marker.
LUAD and KIRP are the cancer types where MIR4503 RNA most reproducibly stratifies survival.